ELEDON PHARMACEUTICALS INC (ELDN)

US28617K1016 - Common Stock

2.29  -0.1 (-4.18%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
43.00M39.78M36.87M16.19M14.18M
Research and Development
30.31M27.08M23.74M6.13M8.13M
Selling, General, and Administrative Expenses
12.69M12.70M13.13M10.05M6.06M
Operating Income
-43.00M-39.78M-36.87M-16.19M-14.18M
Interest Income/Expense
N/AN/AN/AN/AN/A
Other Income/Expense
2.67M460.00K10.00K-4.75M40.00K
Non Recurring Items
0.00-48.65M0.00-2.28M-1.87M
Income Before Taxes
-40.33M-87.97M-36.86M-23.22M-16.01M
Income Tax
0.000.00-2.35M-400.00KN/A
Net Income
-40.33M-87.97M-34.51M-22.81M-16.01M
EBITDA
N/AN/AN/A-16.18M-14.17M
 
Per Share Data
EPS Diluted Total Ops
-1.64-6.16-2.33-15.72-24.25
Non GAAP EPS
-1.79-2.76-2.32-13.21-22.86
 
Statistics

All data in USD

Charts